AstraZeneca AZN announced that the FDA has expanded the label of its cancer drug Datroway for a second indication — non-small ...

FDA updates talazoparib and enzalutamide labeling, confirming survival benefits for HRR-mutated mCRPC, while excluding ...

A Texas law promoting the Trump administration’s “Make America Healthy Again” agenda requires first-ever warning labels on ...

FDA approved to help select patients with metastatic prostate cancer for radioligand therapy before chemotherapy.

Industry experts note some naturally derived ingredients would also require disclosures, leading to consumer confusion.

AbbVie Inc. (NYSE:ABBV) is one of the 12 best healthcare stocks to buy now. On June 12, the US Food and Drug Administration ...

Incyte INCY announced that the FDA has extended the review period for the supplemental new drug application (sNDA) for ...

The US Food and Drug Administration (FDA) has approved the label expansion of AbbVie’s Mavyret (glecaprevir/pibrentasvir) for treating adults and paediatric ...

The company announced that the US FDA has expanded the approved use of its oral antiviral drug Mavyret, developed in ...

“This is a historic day in the decades-long fight against HIV,” Gilead CEO Daniel O’Day said in the company’s announcement.

Editor's Note: This headline and story have been updated to clarify that the FDA approval was for an expanded ... with acute HCV infection supported the label expansion. The study results showed ...

The tablet formulation of zanubrutinib (Brukinsa; BeOne) is now approved for all 5 indications across several hematological ...